Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Un-audited Financial Results for ....
RESULTS
◆ Monitor Closely
LOW RISK
📅 Filed on BSE: 06 Aug 2026, 04:50 PM IST · BSE ID: d19af757-2c0a-43d2-a451-cf3c962e44db
View Original BSE Filing (PDF)
💡
In Simple Terms
Natco Pharma's board will meet on August 14, 2026, to discuss its latest quarterly earnings and a potential interim dividend.
🤖 AI Summary
- Natco Pharma Ltd Board of Directors to convene on August 14, 2026.
- Meeting agenda includes considering Unaudited Financial Results for quarter ended June 30, 2026.
- Board will also deliberate on an interim dividend for the financial year 2026-27.
- Trading window for company securities closed from August 7, 2026, to August 16, 2026.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this notice.
👤
Who Is Affected
Shareholders will be affected by the decisions made at the Board Meeting, specifically regarding quarterly financial performance and any declared interim dividend.
🔍
Management Signal
Management is adhering to regulatory timelines for financial reporting and dividend consideration.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Natco Pharma Ltd Board Meeting outcome on August 14, 2026.
Announcement of Unaudited Financial Results for Q1 FY27.
Details of any interim dividend declared for FY2026-27.
LOW RISK
This is a routine procedural announcement for a board meeting.
💡 Investor Takeaway
Natco Pharma Ltd has scheduled a Board Meeting for August 14, 2026, to consider its Unaudited Financial Results for the quarter ended June 30, 2026. The Board will also review an interim dividend for the financial year 2026-27.
❓ Frequently Asked Questions
When is the Board Meeting for Natco Pharma Ltd scheduled?
The meeting of the Board of Directors of Natco Pharma Ltd is scheduled for Friday, August 14, 2026.
What financial results will the Natco Pharma Board consider?
The Board will consider the Unaudited Financial Results for the quarter ended June 30, 2026.
Will Natco Pharma Ltd consider a dividend at this meeting?
Yes, the Board will consider an interim dividend, if any, for the financial Year ending 2026-27.
When is the trading window closed for Natco Pharma Ltd securities?
The trading window is closed from August 7, 2026, to August 16, 2026 (both days inclusive).
Questions based on this BSE filing only. For information purposes.